VDRM (ViaDerma) LT-Debt-to-Total-Asset: 0.06 (As of Jun. 2012)


What is ViaDerma LT-Debt-to-Total-Asset?

ViaDerma VDRM LT-Debt-to-Total-Asset is 0.06 as of Jun. 2012.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. ViaDerma's long-term debt to total assests ratio for the quarter that ended in Jun. 2012 was 0.06.

ViaDerma's long-term debt to total assets ratio increased from Jun. 2011 (0.03) to Jun. 2012 (0.06). It may suggest that ViaDerma is progressively becoming more dependent on debt to grow their business.

ViaDerma  (OTCPK:VDRM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

ViaDerma LT-Debt-to-Total-Asset Related Terms

ViaDerma LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for ViaDerma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma LT-Debt-to-Total-Asset Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
LT-Debt-to-Total-Asset
0.00 0.06 0.00 0.03 0.08

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.08 0.08 0.07 0.06

ViaDerma LT-Debt-to-Total-Asset Calculation

ViaDerma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2011 is calculated as

LT Debt to Total Assets (A: Dec. 2011 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2011 )/Total Assets (A: Dec. 2011 )
=3.32/42.645
=0.08

ViaDerma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2012 is calculated as

LT Debt to Total Assets (Q: Jun. 2012 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2012 )/Total Assets (Q: Jun. 2012 )
=2.862/45.832
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.06 mean?
ViaDerma (VDRM) has a LT-Debt-to-Total-Asset of 0.06 as of Jun. 2012. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on ViaDerma and its competitors.
Is ViaDerma's LT-Debt-to-Total-Asset too high?
ViaDerma's current LT-Debt-to-Total-Asset is 0.06.
How does ViaDerma's LT-Debt-to-Total-Asset compare to AOLS and RDGL?
ViaDerma's LT-Debt-to-Total-Asset of 0.06 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on ViaDerma and its competitors. ViaDerma's current LT-Debt-to-Total-Asset is 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current LT-Debt-to-Total-Asset of 0.06. The current LT-Debt-to-Total-Asset is 0.06. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For ViaDerma (VDRM), the current LT-Debt-to-Total-Asset is 0.06 as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.